Sunovion Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUNOVION
SUNOVION has one approved drug.
There are six US patents protecting SUNOVION drugs.
There are thirty-nine patent family members on SUNOVION drugs in twenty-two countries and nineteen supplementary protection certificates in sixteen countries.
Summary for Sunovion
| International Patents: | 39 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Sunovion: | See patent lawsuits for Sunovion |
Drugs and US Patents for Sunovion
Expired US Patents for Sunovion
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-001 | Oct 28, 2010 | 9,815,827 | ⤷ Start Trial |
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-004 | Apr 26, 2012 | 9,815,827 | ⤷ Start Trial |
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-004 | Apr 26, 2012 | 9,555,027 | ⤷ Start Trial |
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-005 | Jul 12, 2013 | 9,815,827 | ⤷ Start Trial |
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-003 | Dec 7, 2011 | 9,555,027 | ⤷ Start Trial |
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-005 | Jul 12, 2013 | 9,555,027 | ⤷ Start Trial |
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-003 | Dec 7, 2011 | 9,815,827 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUNOVION drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg | ➤ Subscribe | 2014-10-28 |
International Patents for Sunovion Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Portugal | 1884242 | ⤷ Start Trial |
| Mexico | 2007014872 | ⤷ Start Trial |
| Spain | 2408687 | ⤷ Start Trial |
| Luxembourg | 92550 | ⤷ Start Trial |
| Poland | 1884242 | ⤷ Start Trial |
| Japan | 5285105 | ⤷ Start Trial |
| Hungary | S1400051 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sunovion Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1884242 | C01884242/01 | Switzerland | ⤷ Start Trial | FORMER OWNER: SUMITOMO DAINIPPON PHARMA CO., LTD., JP |
| 1884242 | 1490057-5 | Sweden | ⤷ Start Trial | PRODUCT NAME: LURASIDONE, OPTIONALLY IN THE FORM OF LURASIDONE HYDROCHLORIDE; REG. NO/DATE: EU/1/14/913 20140327 |
| 1884242 | 251 5024-2014 | Slovakia | ⤷ Start Trial | PRODUCT NAME: LURASIDON; REGISTRATION NO/DATE: EU/14/913/001 - EU/14/913/021 20140327 |
| 1884242 | CR 2014 00049 | Denmark | ⤷ Start Trial | PRODUCT NAME: LURASIDON HYDROCHLORID; REG. NO/DATE: EU/1/14/913/001-021 20140327 |
| 1884242 | 14C0069 | France | ⤷ Start Trial | PRODUCT NAME: LURASIDONE, EN PARTICULIER SOUS LA FORME DE L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, NOTAMMENT LE CHLORHYDRATE; REGISTRATION NO/DATE: EU/1/14/913 20140327 |
| 1884242 | 132014902294693 | Italy | ⤷ Start Trial | PRODUCT NAME: LURASIDONE, OPZIONALMENTE IN FORMA DI BASE LIBERA O DI SUOI SALI FARMACEUTICAMENTE ACCETTABILI(LATUDA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/913, 20140321 |
| 1884242 | 56/2014 | Austria | ⤷ Start Trial | PRODUCT NAME: LURASIDON, GEGEBENENFALLS IN FORM SEINER FREIEN BASE ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON.; REGISTRATION NO/DATE: EU/1/14/913 20140327 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
